earnings
confidence high
sentiment positive
materiality 0.75
ResMed Q2 FY2026: Revenue $1.42B (+11% YoY), non-GAAP EPS $2.81, dividend $0.60
RESMED INC
2026-Q2 EPS reported
$5.05
revenue$2,758,390,000
- Revenue $1,422.8M, up 11% YoY (9% constant currency); gross margin expanded 320 bps to 61.8%.
- GAAP diluted EPS $2.68; non-GAAP diluted EPS $2.81, up 16% YoY.
- Operating cash flow $340M; income from operations rose 18% YoY.
- Board declared quarterly cash dividend of $0.60/share, record Feb 12, payable Mar 19.